<code id='204A4B083E'></code><style id='204A4B083E'></style>
    • <acronym id='204A4B083E'></acronym>
      <center id='204A4B083E'><center id='204A4B083E'><tfoot id='204A4B083E'></tfoot></center><abbr id='204A4B083E'><dir id='204A4B083E'><tfoot id='204A4B083E'></tfoot><noframes id='204A4B083E'>

    • <optgroup id='204A4B083E'><strike id='204A4B083E'><sup id='204A4B083E'></sup></strike><code id='204A4B083E'></code></optgroup>
        1. <b id='204A4B083E'><label id='204A4B083E'><select id='204A4B083E'><dt id='204A4B083E'><span id='204A4B083E'></span></dt></select></label></b><u id='204A4B083E'></u>
          <i id='204A4B083E'><strike id='204A4B083E'><tt id='204A4B083E'><pre id='204A4B083E'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:29231
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Health tech investors get more selective as pandemic boom fades
          Health tech investors get more selective as pandemic boom fades

          AdobeVenturefirmsbackinghealthtechstartupsaretelegraphingcautiousoptimismfor2024,advisingstartupstoe

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Results on Novartis prostate cancer therapy could expand its use

          TheNovartisboothatESMO2023inMadrid.AndrewJoseph/STATMADRID—ResultspresentedMondaycouldexpandtheuseof